A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.

Lacourcière, Y; Pool, J L; Svetkey, L; Gradman, A H; Larochelle, P; de Champlain, J; Smith, W B

Lacourcière, Y; Pool, J L; Svetkey, L; Gradman, A H; Larochelle, P; de Champlain, J; Smith, W B.

Affiliation

Lacourcière Y; Hypertension Research Unit, Centre Hospitalier de l'Université Laval, Ste.-Foy, Québec, Canada.

Am J Hypertens ; 11(4 Pt 1): 454-61, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9607384

Subject(s)

Antihypertensive Agents/administration & dosage; Hypertension/drug therapy; Pyrimidines/administration & dosage; Tetrazoles/administration & dosage; Adult; Aged; Antihypertensive Agents/adverse effects; Antihypertensive Agents/therapeutic use; Blood Pressure/drug effects; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm/physiology; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate/drug effects; Humans; Hypertension/physiopathology; Male; Middle Aged; Placebos; Pyrimidines/adverse effects; Pyrimidines/therapeutic use; Tetrazoles/adverse effects; Tetrazoles/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Tetrazoles / Hypertension / Antihypertensive Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Hypertens Journal subject: ANGIOLOGIA Year: 1998 Document type: Article Affiliation country: Canada Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links